Edesa Biotech, Inc. financial statements
Edesa Biotech, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Net income | −USD 7.19M | 10-K |
| Cash and equivalents | USD 10.8M | 10-K |
Edesa Biotech, Inc. financials on 6ix · Edesa Biotech, Inc. on 6ix